Adam Gale, KLAS’ Co-Founder & CEO, speaks with Justin on some of the keystone principles at KLAS Research (provider comes first) and how KLAS’ mission aligns with the healthcare investment community. Adam notes that initially KLAS Research was hesitant to work with healthcare investors because of the uncertainty that some acquisitions seemed money driven, whereas now investors are really in it for the “long-term win” and want to move the market forward. Adam touches on how emerging technology has caught momentum within recent years and has become a focused priority, especially since the pandemic. A key question then is formed around the criteria that is needed to become a spotlight emerging tech KLAS report vendor.